Kusumakar Vivek
Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia, Canada.
J Clin Psychiatry. 2002;63 Suppl 10:23-8.
Antidepressants and antipsychotics are frequently used as mood stabilizers in the treatment of bipolar disorder. As common as these agents appear to be in bipolar treatment, the literature contains little research on their efficacy and safety in the long term. Most of the available literature on long-term antidepressant treatment focuses on tricyclic antidepressants, which have been shown to induce mania or hypomania. Rapid cycling is another side effect that is associated with antidepressant treatment in bipolar disorder. Antidepressants do not appear to be any more effective than mood stabilizers in treating bipolar depression. Conventional antipsychotics in depot formulations have been shown to be an effective treatment, but conventional antipsychotics may cause tardive dyskinesia. The novel antipsychotics clozapine, risperidone, and olanzapine appear to be efficacious; however, their side effect profiles include agranulocytosis and weight gain. Given the frequency with which antidepressants and antipsychotics are used in bipolar disorder and that bipolar disorder is a chronic disease requiring maintenance treatment, more research on the use of these types of agents in long-term treatment is needed. Until more evidence is available on the long-term treatment outcomes, clinicians should be aware that the adverse events associated with antidepressants and antipsychotics may outweigh the benefit, if any, of the use of these agents in bipolar disorder.
抗抑郁药和抗精神病药常用于双相情感障碍的治疗中作为心境稳定剂。尽管这些药物在双相情感障碍治疗中似乎很常用,但文献中关于它们长期疗效和安全性的研究却很少。现有的关于长期抗抑郁药治疗的大部分文献都集中在三环类抗抑郁药上,这类药物已被证明会诱发躁狂或轻躁狂。快速循环是双相情感障碍抗抑郁药治疗相关的另一种副作用。在治疗双相抑郁方面,抗抑郁药似乎并不比心境稳定剂更有效。长效剂型的传统抗精神病药已被证明是一种有效的治疗方法,但传统抗精神病药可能会导致迟发性运动障碍。新型抗精神病药氯氮平、利培酮和奥氮平似乎有效;然而,它们的副作用包括粒细胞缺乏症和体重增加。鉴于抗抑郁药和抗精神病药在双相情感障碍中使用的频率,以及双相情感障碍是一种需要维持治疗的慢性疾病,需要对这些类型药物在长期治疗中的使用进行更多研究。在获得更多关于长期治疗结果的证据之前,临床医生应该意识到,与抗抑郁药和抗精神病药相关的不良事件可能超过在双相情感障碍中使用这些药物的任何益处(如果有的话)。